CORD-19:013ce450f63ae2496b92f987e35b55125a43947f / 12250-12355
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T55","span":{"begin":0,"end":31},"obj":"Sentence"},{"id":"TextSentencer_T56","span":{"begin":32,"end":105},"obj":"Sentence"},{"id":"TextSentencer_T55","span":{"begin":0,"end":31},"obj":"Sentence"},{"id":"TextSentencer_T56","span":{"begin":32,"end":105},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These questions were addressed: Is PRCV a more effective candidate vaccine for TGEV than attenuated TGEV?"}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T55","span":{"begin":0,"end":31},"obj":"Sentence"},{"id":"T56","span":{"begin":32,"end":105},"obj":"Sentence"}],"text":"These questions were addressed: Is PRCV a more effective candidate vaccine for TGEV than attenuated TGEV?"}
Epistemic_Statements
{"project":"Epistemic_Statements","denotations":[{"id":"T20","span":{"begin":0,"end":105},"obj":"Epistemic_statement"}],"text":"These questions were addressed: Is PRCV a more effective candidate vaccine for TGEV than attenuated TGEV?"}